Diana Bautista, a 2009 Pew scholar and assistant professor of molecular and cell biology at University of California, Berkeley, was featured in a segment of Morning Edition, explaining the vibrating sensation we experience when we eat Sichuan peppers. Her research on the nerve cells involved in the response to spicy food could unveil possible treatments for tingling and numbing paresthesia, or chronic “pins and needles.”More info
''NIH names Dr. Gary H. Gibbons director of the National Heart, Lung, and Blood Institute''
National Institutes of Health Director Francis S. Collins M.D., Ph.D., announced today the selection of Gary H. Gibbons, M.D., as the new director of the NIH's National Heart, Lung, and Blood Institute (NHLBI). Dr. Gibbons is the founder and current director of the Cardiovascular Research Institute, chairperson of the Department of Physiology, and professor of physiology and medicine at the Morehouse School of Medicine in Atlanta. He expects to start his new position in the summer of 2012.
Gibbons' institute at Morehouse is recognized for its discovery science related to cardiovascular health of minority populations. His laboratory is focused on discovering novel mediators of vascular disease. His program involves collaborative efforts to study the functional significance of genomic variation and changes in gene activities due to 'epigenetic' modifications of DNA that do not involve a change in the genetic code, as factors that enhance the susceptibility to cardiovascular disease.
"It is my sincere pleasure to welcome Dr. Gibbons to the NIH team," said Collins. His extraordinary scientific skills, tremendous energy and bold vision will be an asset to NHLBI and NIH." Susan B. Shurin, M.D., will continue as acting director of NHLBI until Gibbons joins, at which point she will resume her role as the institute's deputy director. "I want to extend my deep gratitude to Susan for her strong leadership in this role," added Collins.
Gibbons will oversee the third largest institute at the NIH, with an annual budget of more than $3 billion and a staff of 917 federal employees. Gibbons will also direct his own lab at the NIH, focusing on predictive health and genomic medicine in minority populations. The NHLBI provides global leadership for research, training, and education programs to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives.
"It's an honor to join the NIH and lead the Heart, Lung, and Blood Institute," said Gibbons. "The globally recognized research and training supported by the NHLBI continues to advance biomedical knowledge in fields related to heart, lung, and blood diseases. I look forward to working with the institute staff and with the many researchers supported by the Institute to foster multidisciplinary approaches to improve disease prevention, diagnosis, and treatment that will advance the health of all Americans."
Gibbons has served as a member of the National Heart, Lung, and Blood Advisory Council (NHLBAC) since 2009, a position he resigned after being selected to be director of the NHLBI. He was also a member of the NHLBI Board of Extramural Experts, a working group of the NHLBAC. Gibbons has received 15 NHLBI-supported grants since 1997.
Under his leadership of the Cardiovascular Research Institute at the Morehouse School of Medicine, Gibbons directed NIH-supported research in the fields of vascular biology, genomic medicine, and the pathogenesis of vascular diseases. During his tenure, the Cardiovascular Research Institute emerged as a center of excellence, leading the way in discoveries related to the cardiovascular health of minority populations. Gibbons has received several patents for innovations derived from his research in the fields of vascular biology and the pathogenesis of vascular diseases.
Gibbons, who is originally from Philadelphia, earned his undergraduate degree from Princeton University in Princeton, N.J., and graduated magna cum laude from Harvard Medical School in Boston. He completed his residency and cardiology fellowship at the Harvard-affiliated Brigham and Women's Hospital in Boston. Prior to joining the Morehouse School of Medicine in 1999, Dr. Gibbons was a member of the faculty at Stanford University, in Stanford, Calif., from 1990 until1996, and Harvard Medical School from 1996 until 1999.
Throughout his career, Gibbons has received numerous honors, including election to the Institute of Medicine of the National Academies of Sciences; selection as a Robert Wood Johnson Foundation Minority Faculty Development Fellowship awardee; selection as a Pew Biomedical Scholar by the Pew Charitable Trusts; and recognition as an Established Investigator of the American Heart Association (AHA).
Dr. Gibbons also serves on several editorial boards for journals in cardiovascular medicine, the Juvenile Diabetes Foundation, and the AHA.
* * *Full Article
- Date added:
- Apr 5, 2012
In January, Antonio Giraldez, a 2008 Pew Scholar, was awarded the Vilcek Prize for Creative Promise in Biomedical Science for his research on the role of microRNAs in the early developmental stages of vertebrates.More info
The sensation of feeling itchy is pretty universal, and yet scientists still don't completely understand the complex processes that give us the urge to scratch.More info
Two BU researchers will travel to Washington, D.C., later this year to accept the Presidential Early Career Award for Scientists and Engineers (PECASE), one of the highest honors for young science and engineering professionals.More info
In October, 2013 Pew scholar Shelly Peyton won the NIH Director’s New Innovator Award, a five-year, $2.4 million grant from the National Institutes of Health. With the funds, the assistant professor at University of Massachusetts, Amherst, is focusing on cancer spread—and the possibility that some cancer treatments might speed up the process.More info
Wired magazine has compiled a list of the year’s best scientific visualizations—including an image by 2013 Pew scholar Viviana Gradinaru. In collaboration with other researchers at California Institute of Technology, the assistant professor created a technique to make fatty tissues translucent and color-coded for easier study.More info
Mark Davis, a 1985 Pew scholar and director of Stanford University’s Institute for Immunity Transplantation and Infection, is featured in US News & World Report for his research on how men and women respond differently to influenza vaccines. His study, published in the Proceedings of the National Academy of Sciences, is the first to demonstrate a correlation between testosterone levels, gene expression, and immune responsiveness in humans.More info
1996 Pew scholar Carolyn Bertozzi, the T.Z. and Irmgard Chu Distinguished Professor of Chemistry at the University of California, Berkeley and a Howard Hughes Medical Investigator, has been elected into the National Academy of Inventors for her contributions to the field of chemistry. Bertozzi’s innovations include copper-free click chemistry, a technique for examining sugars on cell surfaces without doing harm to the cell.More info
The American Association for the Advancement of Science, or AAAS, on Nov. 25 named 338 new fellows, including Pew biomedical scholars James Bliska (1994), M. Bishr Omary (1989), and Richard Padgett (1986). AAAS fellows are selected based on their demonstrated efforts to advance science or its applications.More info
Gregory Amberg, a 2010 Pew scholar and assistant professor of biomedical sciences at Colorado State University, has won a $1.8 million grant from the National Institutes of Health to study how high blood pressure develops in people with obesity. With the five-year award, Amberg hopes to identify the underlying causes for the cardiovascular disease, with the aim of developing therapies to prevent its organ-damaging effects.More info
Manu Prakash, a 2013 Pew scholar and assistant professor of bioengineering at Stanford University, has been awarded a Grand Challenges Explorations Grant from the Bill & Melinda Gates Foundation. As one of 81 winners selected from more than 2,700 proposals, Prakash’s team will develop an inexpensive electromagnetic detection device to diagnose infections of parasitic worms in people.More info